What are the 10-year clinical outcomes and valve durability after Transcatheter Aortic Valve Implantation with balloon-expandable valves in older adult high-risk patients?
In older, high-risk patients undergoing TAVI with balloon-expandable valves, 10-year survival is primarily limited by baseline comorbidities rather than structural valve dysfunction, supporting its long-term feasibility.
Few older adult high-risk patients survived beyond 10 years following TAVI. In contrast, transcatheter heart valve demonstrated acceptable durability, and long-term outcomes were primarily determined by baseline comorbidities rather than valve dysfunction. These results support the role of TAVI as a feasible therapeutic approach in this population.
Ikuta et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: